Welcome to our dedicated page for Marchex news (Ticker: MCHX), a resource for investors and traders seeking the latest updates and insights on Marchex stock.
Marchex, Inc. develops AI-powered conversational intelligence and analytics solutions that turn customer communications into operating, sales, marketing, and service insights. The company focuses on B2B2C vertical markets, including automotive, home services, healthcare, real estate, advertising, franchising, and multi-unit retail, and operates around conversational analytics and related solutions.
Marchex news commonly covers product availability and platform updates such as the Marchex Engage Platform, integrations for healthcare and automotive workflows, customer deployments, franchise and location-level performance analytics, and quarterly or annual financial results. Updates also address omnichannel conversation data, campaign attribution, lead handling, benchmarking, and operational performance tools for enterprise and distributed-location customers.
Marchex (NASDAQ:MCHX) reported Q1 2026 GAAP revenue of $10.6 million, down from $11.4 million in Q1 2025. Net loss was $1.7 million ($0.04 per share) versus $2.0 million ($0.05) a year ago, and adjusted EBITDA loss improved to $0.1 million.
The company expects sequential revenue growth in Q2 and Q3 2026 and now guides Q2 adjusted EBITDA to $1.6–$1.8 million, with standalone Q3 potentially around $2 million. On May 8, 2026 Marchex signed a stock purchase agreement to acquire Archenia, targeting July 2026 closing, and estimates the combined business could reach roughly $15 million quarterly revenue and adjusted EBITDA margins of 10%+ in 2026.
Marchex (NASDAQ:MCHX) launched Agent Behaviors, an AI-powered solution within the Marchex Engage Platform to analyze and score agent performance in customer conversations.
The tool provides automated behavioral scoring and analytics to help franchises, dealers, and other organizations improve appointment rates, sales execution, and customer satisfaction through more targeted coaching.
Marchex (NASDAQ: MCHX) will report first quarter 2026 financial results for the period ended March 31, 2026, on Wednesday, May 13, 2026 at approximately 4:20 p.m. ET.
Management will host a conference call at 5:00 p.m. ET the same day with a live webcast available on the company investor website and an archived recording posted about two hours after the call.
Marchex (NASDAQ: MCHX) announced that the Marchex Engage Platform is now broadly available to customers, including Marketing Edge Advantage clients. The AI-powered platform offers KPI dashboards, configurable analytics, industry benchmarking, personalized recommendations, call logs, and links metrics to revenue impact to help close performance gaps.
Early customer feedback highlights actionable insights, including identification of >$60,000 in wasted spend from affiliate-driven calls.
Marchex (NASDAQ: MCHX) reported GAAP revenue of $10.8M in Q4 2025 and $45.4M for full-year 2025, with net losses of $2.3M Q4 and $5.2M FY. Adjusted EBITDA was a $1.2M loss in Q4 and a $0.7M loss for 2025, including reorganization and acquisition-related costs.
The company completed primary migration of ~1,000 customers to a new AI platform in late 2025 and is pursuing a proposed acquisition of Archenia, which estimates >$17M revenue in 2025. Marchex projects 2026 sequential revenue growth, ~10% run-rate growth from 2025 year-end, and Adjusted EBITDA margins of 10%+ assuming closing of the Archenia transaction.
Marchex (NASDAQ: MCHX) launched an integration with Freshpaint on March 24, 2026 to connect Marchex’s AI conversation intelligence with Freshpaint’s privacy-by-design data platform.
The integration securely links inbound call and conversation data to marketing platforms, enabling healthcare marketers to attribute digital spend to booked appointments, optimize campaigns, and improve automated bidding while protecting patient privacy.
Marchex (NASDAQ: MCHX) will report fourth quarter and full year 2025 financial results on Wednesday, March 25, 2026 at approximately 4:20 p.m. ET. Following the release, management will host a conference call at 5:00 p.m. ET the same day.
A live webcast will be available on the company's Investors website and an archived version will be posted about two hours after the call.
Marchex (NASDAQ: MCHX) said PDS Health expanded use of its AI-powered conversation intelligence to link marketing activity to patient engagement and appointment outcomes. PDS Health reduced marketing cost per lead by ~20% using Marchex signals, while integrating insights into CRM and reporting for privacy-conscious attribution and budget optimization.
Marchex (NASDAQ: MCHX) announced an integration with Solera to bring Marchex’s AI-driven conversation intelligence into Solera’s SaaS platform for automotive dealerships on February 25, 2026. The integration aims to reduce manual data handling, improve speed and accuracy, and help dealer sales teams focus on closing deals.
The companies said the open integration approach lowers costs for dealers while adding value-added features and functionality.
Marchex (NASDAQ: MCHX) will showcase its AI-powered conversation intelligence at the International Franchise Association (IFA) Convention 2026. The company highlights tools for franchise brands to improve booking rates, marketing ROI, agent performance, and consistency across multi-location networks.
Attendees can visit Booth #407 or schedule a virtual demo to see the Agent Performance Suite and analytics that surface lead outcomes, conversion gaps, and coaching opportunities across sectors like home services and automotive.